Mgr. Václav Šeda, Ph.D.
junior researcher – Výzkumná skupina Marka Mráze
kancelář: bud. E35/281
Kamenice 753/5
625 00 Brno
telefon: | 549 49 7500 |
---|---|
e‑mail: |
Počet publikací: 80
2018
-
miR-150 downregulation contributes to the high-grade transformation of follicular lymphoma by upregulating FOXP1 levels
Blood, rok: 2018, ročník: 132, vydání: 22, DOI
-
MYC-mediated downregulation of miR-150 contributes to the transformation of follicular lymphoma by upregulating FOXP1 levels
Rok: 2018, druh: Konferenční abstrakty
-
MYC-mediated downregulation of miR-150 contributes to the transformation of follicular lymphoma to DLBCL by upregulating FOXP1 levels
Rok: 2018, druh: Konferenční abstrakty
-
Rituximab primarily targets an intra-clonal BCR signaling proficient CLL subpopulation characterized by high CD20 levels
Leukemia, rok: 2018, ročník: 32, vydání: 9, DOI
-
Selective CHK1 inhibitor MU380 exhibits single-agent activity against chronic lymphocytic leukemia cells with TP53 mutations
Rok: 2018, druh: Konferenční abstrakty
2017
-
BCR signalling proficient chronic lymphocytic leukaemia cells are prone to rituximab mediated elimination in vivo.
Rok: 2017, druh: Konferenční abstrakty
-
Differential expression of microRNAs in transformation of follicular lymphoma to diffuse large B cell lymphoma
Rok: 2017, druh: Konferenční abstrakty
-
Down-regulation of miR-150 and up-regulation of its target FOXP1 is associated with transformation of follicular lymphoma.
Rok: 2017, druh: Konferenční abstrakty
-
MicroRNA induced by DNA damage response regulate the expression of FOXP1 and therapy response in CLL
Rok: 2017, druh: Konferenční abstrakty
-
MicroRNA induced by DNA damage response regulates the expression of FOXP1 and therapy response in CLL
Rok: 2017, druh: Konferenční abstrakty